Real life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: a prospective cohort study with solifenacin

Marloes Tijnagel; Jeroen Scheepe; Bertil Blok

doi:10.1186/s12894-017-0216-4

Real life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: a prospective cohort study with solifenacin

Marloes Tijnagel, Jeroen Scheepe, Bertil Blok

Urology

Research output: Contribution to journal › Article › Academic › peer-review

21 Citations (Scopus)

20 Downloads (Pure)

Original language	Undefined/Unknown
Article number	30
Journal	BMC Urology
Volume	17
DOIs	https://doi.org/10.1186/s12894-017-0216-4
Publication status	Published - 2017

Research programs

EMC OR-01-49-02

Access to Document

10.1186/s12894-017-0216-4

REPUB_99623-OA.pdfFinal published version, 406 KB

http://hdl.handle.net/1765/99623

Cite this

@article{4b7fad045f694a7ba8a5834ec7369d0d,

title = "Real life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: a prospective cohort study with solifenacin",

author = "Marloes Tijnagel and Jeroen Scheepe and Bertil Blok",

year = "2017",

doi = "10.1186/s12894-017-0216-4",

language = "Undefined/Unknown",

volume = "17",

journal = "BMC Urology",

issn = "1471-2490",

publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - Real life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: a prospective cohort study with solifenacin

AU - Tijnagel, Marloes

AU - Scheepe, Jeroen

AU - Blok, Bertil

PY - 2017

Y1 - 2017

U2 - 10.1186/s12894-017-0216-4

DO - 10.1186/s12894-017-0216-4

M3 - Article

C2 - 28403849

SN - 1471-2490

VL - 17

JO - BMC Urology

JF - BMC Urology

M1 - 30

ER -